Detection of extrathoracic metastases by positron emission tomography in lung cancer.

[1]  G. Patterson,et al.  Improvement in staging of esophageal cancer with the addition of positron emission tomography. , 1997, The Annals of thoracic surgery.

[2]  R. Coleman,et al.  Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.

[3]  G. V. von Schulthess,et al.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.

[4]  M. J. Fusselman,et al.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. , 1996, Radiology.

[5]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  A. Buck,et al.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Reed,et al.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography. , 1995, American journal of respiratory and critical care medicine.

[8]  P. Valk,et al.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.

[9]  J M Hoffman,et al.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  B. Littenberg,et al.  The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. , 1994, American journal of respiratory and critical care medicine.

[11]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[12]  E. Cronin,et al.  Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions. , 1990, Radiology.

[13]  P. Friedman,et al.  Lung cancer: update on staging classifications. , 1988, AJR. American journal of roentgenology.

[14]  T Jones,et al.  Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.

[15]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .